Get notified when VXRT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Critical incident detected

Existential event · Existential event

Time-sensitive event — see the red-flag panel below for the source-quoted detail.

Red Flags Detected

  • Going Concern (new) — The company explicitly states substantial doubt about its ability to continue as a going concern due to recurring losses and negative cash flows.
  • Delisted (new) — Vaxart's common stock was delisted from Nasdaq and now trades on OTCQX, which may reduce liquidity and investor access.
OTC: VXRT Vaxart, Inc. 424B5

Vaxart launches at-the-market offering of up to $49.8M at $0.63/share, with immediate $0.23/share dilution

Filed May 4, 2026 · ~1 min read

Key Changes

  • high

    Vaxart may sell up to $49,772,479 of common stock in an at-the-market offering, with no minimum amount required to close.

    The Offering verify on EDGAR →
  • high

    At the assumed $0.63 price, new investors face immediate dilution of $0.23 per share, as net tangible book value rises to only $0.40 per share.

    Dilution verify on EDGAR →
  • medium

    The company plans to use net proceeds for general corporate purposes, including working capital, operating expenses, and capital expenditures.

    Use of Proceeds verify on EDGAR →

3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.

Partner

Trade VXRT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify